Acil
Business·03.06.2026AI özeti
Pharma giants scale back German investments amid government cuts
US pharma giant Eli Lilly is significantly reducing its planned multi-billion dollar investment in a new production site in Alzey, Germany. Competitor Boehringer Ingelheim is also halting a high three-digit million euro investment in German sites. Both companies cite government austerity plans in healthcare as a primary reason.
D
Die Zeit